Fibrinopeptide A (FPA) levels have been followed sequentially in a three‐year study of 50
patients with advanced carcinoma. Evidence for activation of blood coagulation was found in …

In 124 patients with various types of malignancy, fpA and ΔfpA were measured. In 35 of
these patients the effect of heparin injection on fpA and ΔfpA was studied. All patients were …

Plasma fibrinopeptide A (FPA) levels were determined in 20 unselected adult patients with
acute nonlymphocytic and lymphocytic leukemia. The mean FPA level in patients with active …

As solid tumours rely upon the bloodstream to deliver nutrients necessary for growth, it
follows that interference with that supply may compromise tumour growth. Indeed, this …

Abstract purpose, patients, and methods: Blood coagulation abnormalities are common in
patients with cancer, particularly after treatment with chemotherapeutic agents …

Routine blood coagulation tests were performed on 431 consecutive patients enrolled in a
study of the role of anticoagulation in cancer treatment (VA Cooperative Study# 75). Two …

FPA level, fibrinogen turnover rate, and fibrinolytic activity were studied on 18 patients with
malignant disease. It was found that the FPA levels were significantly elevated and were …

The activity of cancer procoagulant (CP), prothrombin time (PT), activated partial
thromboplastin time (APTT), the concentration of thrombin–antithrombin complexes (TAT) …

Blood coagulation test results were collected prospectively in patients with previously
untreated, advanced lung or colon cancer who entered into a clinical trial. In patients with …

Since thrombin cleaves fibrinopeptides A (FPA) and B from the NH2-terminal end of the
fibrinogen molecule, measurement of fibrinopeptide levels in plasma may provide a direct …